Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 12/20 | 0.61 |
| ▸ | ADRB3 | P13945 | 13/20 | 0.61 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7989848 | 1.00 | ADRB1 (0.61) | ADRB1ADRB3ADRB2CA1CA2 | |
| Hydrochloric Acid SCHEMBL6624302 | 0.86 | ADRB1 (0.61) | ADRB1ADRB3ADRB2CA1CA2 | |
| SCHEMBL6621605 | 0.85 | ADRB3 (0.68) | ADRB1ADRB3ADRB2 | |
| SCHEMBL6621598 | 0.85 | ADRB3 (0.68) | ADRB1ADRB3ADRB2 | |
| SCHEMBL7989681 | 0.85 | ADRB3 (0.71) | ADRB1ADRB3ADRB2 | |
| Hydrochloric Acid SCHEMBL6620983 | 0.84 | ADRB3 (0.67) | ADRB1ADRB3ADRB2 | |
| Hydrochloric Acid SCHEMBL6620987 | 0.84 | ADRB3 (0.67) | ADRB1ADRB3ADRB2 | |
| Hydrochloric Acid SCHEMBL6620427 | 0.82 | ADRB3 (0.77) | ADRB1ADRB3ADRB2 | |
| Hydrochloric Acid SCHEMBL6620311 | 0.81 | ADRB3 (0.61) | ADRB1ADRB3ADRB2 | |
| SCHEMBL7993072 | 0.79 | ADRB3 (0.59) | ADRB1ADRB3ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6291491-B1 | TREATMENT OF TYPE II DIABETES AND OBESITY; ANTIDEPRESSANTS; DECREASE GUT MOTILITY. | MERCK & CO., INC. | 2001-09-18 | — | — | US | disclosed |